South Korea biotech investment rises 53.6% to four-year high

Verifying
  • South Korea’s biotech and medical sector attracted 1.5041 trillion won in first-half venture investment.
  • 1.5041 trillion won represented a 53.6% year-on-year increase and a four-year high.
  • 2022 funding peaked at 1.3159 trillion won before halving and entering a deep freeze.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.